Form 4: Insmed Inc. CEO William Lewis Exercises Stock Options and Adjusts Beneficial Ownership

William Lewis, Chair and CEO of Insmed Inc., exercised stock options and adjusted his reported beneficial ownership due to a clerical error.

Summary

• On February 28, 2024, William Lewis, the Chair and CEO of Insmed Inc., exercised stock options to acquire 50,000 shares of common stock at a price of $12.58 per share.
• This transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
• Following the transaction, Lewis directly owns 363,616 shares of Insmed Inc.
• Additionally, his indirect ownership includes 50,500 shares held by ARTICLE 4 UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A11/1/2020 and 233,924 shares held by ARTICLE 4 KATIE PROCTER DYNASTY TRUST.
• A clerical error related to previously withheld shares for tax obligations was corrected, decreasing the amount beneficially owned by 35 shares.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, so the sentiment is neutral. It reflects standard insider trading activity.

Positives

• The exercise of stock options by the CEO could be interpreted as a sign of confidence in the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC when company insiders, like the CEO, trade in their company's stock. These filings provide transparency to the market about insider activity.

Stakeholder Impact

• The transaction could have a minor impact on shareholders, as it reflects insider activity, but is unlikely to be significant.

Key Dates